Neuropace Inc at JPMorgan Healthcare Conference Transcript
Good morning, everyone. I'm Lily Lozada. I'm on the medtech team here at JPMorgan, and I'm happy to have the NeuroPace management team with us here today. I'll pass things off to CEO, Mike Favet, before we open things up for Q&A.
Thank you. Good morning, everyone. I am here today to tell you about what's happening in NeuroPace. So starting with a little bit of an overview for people that are not as familiar with the story. At NeuroPace, our mission is to transform the lives of people living with epilepsy. The condition itself, epilepsy is a condition that affects about 3.4 million people in the United States, has a tremendous cost to the health care system, impact to patients, impact to family members and caregivers of patients. And many of those patients are looking for treatment options when medical management does not work for them. And that's the place that NeuroPace comes in.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
